Developer docs
API playgroundTry for free, no card

Search company profiles

Walletmor

Full company profile

uuid000apv8

Namestring
Walletmor
Legal namestring
Walletmor Ltd
Websiteurl
walletmor.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Walletmor is a Polish-British startup founded in 2021 that sells the world's first commercially available, globally accepted subdermal NFC payment implant. The implant is a passive transponder — a silicon chip containing encrypted payment data and an NFC antenna, encapsulated in a USP Class VI certified biopolymer developed with VivoKey Technologies — that is implanted under the skin (typically in the hand) and enables contactless payments at any terminal accepting Visa/Mastercard contactless. The implant carries ISO 10993 biocompatibility certification and FDA-cleared materials, and communicates via the ISO 14443A protocol using EMV and 3-D Secure standards. The current-generation product has an 8-year validity period.

The company sells the implant directly to consumers through its Shopify e-commerce storefront at €299 (regular price €499), with free standard shipping and a €20 express option via DHL Express. There is no subscription, transaction fee, or licensing component — revenue is generated entirely from one-time hardware sales plus a small shipping fee. For EU/EEA/Swiss/UK customers, the implant is linked to an iCard digital wallet account; for US customers, it is linked to a Purewrist account. Distribution relies on a network of 100+ vetted installation partners across Europe, the US, and Scandinavia — including body modification artists, piercers, and medical clinics — which are listed on the Walletmor website. As of April 2021, the company reported approximately 200 active users across the UK, Germany, Poland, and Scandinavia, making it a niche, early-adopter business.

Walletmor is registered in London (Walletmor Ltd, Companies House no. 13048848) and operates across 30+ European countries plus the United States. The leadership team consists of CEO and founder Wojciech Paprota, CTO Amal Graafstra (also founder of VivoKey Technologies and Dangerous Things), and CLO Artur Bilski. Marketing is primarily organic and earned media, including a Money20/20 speaking slot and a Museum of the Future exhibition in Dubai. No institutional funding rounds are disclosed. The company has announced a planned adjacent product called Walletmed — a subdermal glucose-monitoring implant for diabetics — which would extend the implant technology into healthcare but has not yet been launched.

Short descriptiontext

Walletmor sells the world's first commercially available NFC payment implant — a subdermal biopolymer chip that enables contactless payments worldwide. The company sells directly to consumer early adopters via Shopify and distributes installation through 100+ vetted body modification and medical partners across Europe and the US.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
NFC payment implants, contactless payment hardware, subdermal payment chips, biopolymer implant devices, contactless payment technology
Industry4 codes
PRIMARYFSAMAEAB
Mobile Wallets (NFC Tap-to-Pay / HCE)
SECONDARYFSAMAEAM
Embedded Wallets (Platforms & Marketplaces)
SECONDARYHDACAKAG
Payment PIN Pads, Card Readers & NFC Contactless Devices
SECONDARYBPAMAFAC
Digital Wallet Platforms (Consumer & Merchant)
Business & Public Services/Web, Mobile & Digital Platforms/Payments, Wallets & Digital Banking Platforms
Product category
Contactless Payment Hardware
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Implant Hardware Sales
TypeOne Time License
Description

One-time sale of the Walletmor payment implant device. The implant is sold directly to consumers through the Shopify e-commerce platform. No subscription fees or maintenance charges apply. Revenue is generated entirely from the initial product purchase.

walletmor.com
2Shipping Fees
TypeHardware Sales
Description

Revenue generated from shipping charges for express delivery options. Standard shipping is free; express shipping via DHL Express costs €20.

walletmor.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Marketing or Sales, Operations, Personnel, Infrastructure
Pricing details5 tiers
1Walletmor Payment Implant (8-year validity) - Current generation
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Current price: €299 (regular price €499). 8-year validity from date of purchase. Includes the implant device, activation code, and instructions. Tax included. No subscription or maintenance fees.

walletmor.com
2Legacy Implant (2-year validity) - Discontinued generation
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Promotional price of €99 for remaining stock. Valid until end of July 2023. Discontinued after June 17, 2021 when 8-year version launched.

walletmor.com
3Standard Shipping
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Free shipping via standard national post. Delivery time up to 10 working days.

walletmor.com
4Express Shipping (DHL Express)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Paid express shipping at €20 via DHL Express. Delivery time up to 3 working days.

walletmor.com
5US Version Implant
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

US-specific version priced at €299. Includes Purewrist app integration instead of iCard. Available for US residents.

walletmor.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Walletmed
Description

A pivot of Walletmor targeting the diabetics market using smart implant technology for glucose monitoring. Plans to create an implant that is irreplaceable, convenient, connected to smartphone, and potentially 10x cheaper than standard glucometers within 10 years.

walletmor.com
Core offering1 text field

Walletmor designs, manufactures, and sells a subdermal NFC payment implant — a passive transponder consisting of a silicon chip and antenna encapsulated in FDA-confirmed, USP Class VI certified biopolymer. Once implanted (typically in the hand), the device enables contactless payments at any Visa/Mastercard contactless terminal worldwide by linking to an iCard (EU) or Purewrist (US) digital wallet account. The product is sold directly to consumers via e-commerce, with installation arranged separately through partner specialists.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 72.1% of surveyed Poles worry about wallet/card theft, driving demand for theft-proof payment solutions like implants
+4 more records
Product overview1 text field

Walletmor offers a single core product - the Walletmor Payment Implant - which is a subdermal NFC-based payment device. The implant consists of an NFC chip (storing encrypted payment data), an NFC antenna (for terminal communication), and biopolymer encapsulation. For European customers, the implant links with iCard digital wallet; for US customers, it links with Purewrist. The company plans future expansion through Walletmed - a glucose monitoring implant for diabetics. Walletmor Ltd, registered in London, developed the world's first globally accepted payment implant launched in April 2021.

Product and service2 records
1Walletmor Payment Implant (EU Version)
CategoryPayment Implant Hardware
Description

Subdermal NFC payment implant — a passive transponder with silicon chip and antenna in biocompatible biopolymer casing, designed for permanent implantation (typically in the hand). Enables contactless payments at any Visa/Mastercard contactless POS terminal worldwide by linking to an iCard EU digital wallet account. 8-year validity, sold at €299 (regular €499) with no subscription or per-transaction fees.

2Walletmor Payment Implant (US Version)
CategoryPayment Implant Hardware
Description

US-specific version of the Walletmor subdermal NFC payment implant with identical technical specifications as the EU version, but links to Purewrist digital wallet app for US residents instead of iCard. Priced at €299.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-01-01
Description

Seattle-based VivoKey Technologies developed the biocompatible biopolymer used in Walletmor implants. Amal Graafstra, VivoKey founder, serves as Walletmor's CTO. VivoKey is the world's largest producer of its kind implementing the digital identity ecosystem. Their laboratory created the safe biopolymer with USP Class VI certification.

Strategic tierCoreTypeTechnology or Integration
Description

iCard is an independent Financial Institution registered in the European Union holding EMI (Electronic Money Institution) status. Walletmor implants are linked to iCard personal accounts for fund storage. iCard follows strict EU regulations for risk management and security. Customers set up iCard accounts to store disposable funds that are accessed via the implant for contactless payments.

Strategic tierCoreTypeTechnology or Integration
Description

Purewrist is an independent digital wallet provider for US customers. US version of Walletmor implant links to Purewrist app instead of iCard. Users register at Purewrist, verify identity, and top up accounts for implant-based payments.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

UK-based installation partner with multiple locations including Ipswich, Brackley, and Norwich. Professional body modification specialists offering Walletmor implant installation services.

5Dr. Szymon Manasterski / Centrum Medyczne Michalak
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Orthopedic specialist at Michalak Medical Center in Wrocław, Poland. Recommended Walletmor installation partner specializing in musculoskeletal orthopedics and traumatology. Performs quick 4-minute implantation procedures under local anesthesia.

walletmor.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Weaknesses1 record

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Walletmor

Contactless Payment Hardwarewalletmor.com

Walletmor sells the world's first commercially available NFC payment implant — a subdermal biopolymer chip that enables contactless payments worldwide. The company sells directly to consumer early adopters via Shopify and distributes installation through 100+ vetted body modification and medical partners across Europe and the US.

What Walletmor does

Walletmor is a Polish-British startup founded in 2021 that sells the world's first commercially available, globally accepted subdermal NFC payment implant. The implant is a passive transponder — a silicon chip containing encrypted payment data and an NFC antenna, encapsulated in a USP Class VI certified biopolymer developed with VivoKey Technologies — that is implanted under the skin (typically in the hand) and enables contactless payments at any terminal accepting Visa/Mastercard contactless. The implant carries ISO 10993 biocompatibility certification and FDA-cleared materials, and communicates via the ISO 14443A protocol using EMV and 3-D Secure standards. The current-generation product has an 8-year validity period.

The company sells the implant directly to consumers through its Shopify e-commerce storefront at €299 (regular price €499), with free standard shipping and a €20 express option via DHL Express. There is no subscription, transaction fee, or licensing component — revenue is generated entirely from one-time hardware sales plus a small shipping fee. For EU/EEA/Swiss/UK customers, the implant is linked to an iCard digital wallet account; for US customers, it is linked to a Purewrist account. Distribution relies on a network of 100+ vetted installation partners across Europe, the US, and Scandinavia — including body modification artists, piercers, and medical clinics — which are listed on the Walletmor website. As of April 2021, the company reported approximately 200 active users across the UK, Germany, Poland, and Scandinavia, making it a niche, early-adopter business.

Walletmor is registered in London (Walletmor Ltd, Companies House no. 13048848) and operates across 30+ European countries plus the United States. The leadership team consists of CEO and founder Wojciech Paprota, CTO Amal Graafstra (also founder of VivoKey Technologies and Dangerous Things), and CLO Artur Bilski. Marketing is primarily organic and earned media, including a Money20/20 speaking slot and a Museum of the Future exhibition in Dubai. No institutional funding rounds are disclosed. The company has announced a planned adjacent product called Walletmed — a subdermal glucose-monitoring implant for diabetics — which would extend the implant technology into healthcare but has not yet been launched.

Walletmor firmographics

Firmographics
Name
Walletmor
Legal name
Walletmor Ltd
Website
https://walletmor.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
Walletmor sells the world's first commercially available NFC payment implant — a subdermal biopolymer chip that enables contactless payments worldwide. The company sells directly to consumer early adopters via Shopify and distributes installation through 100+ vetted body modification and medical partners across Europe and the US.
Ownership category
akta.pro rank

Walletmor industry classification

Industry
Product category
Contactless Payment Hardware
akta.pro industry
PRIMARYFSAMAEAB
Mobile Wallets (NFC Tap-to-Pay / HCE)
SECONDARYFSAMAEAM
Embedded Wallets (Platforms & Marketplaces)
SECONDARYHDACAKAG
Payment PIN Pads, Card Readers & NFC Contactless Devices
SECONDARYBPAMAFAC
Digital Wallet Platforms (Consumer & Merchant)
Business & Public Services/Web, Mobile & Digital Platforms/Payments, Wallets & Digital Banking Platforms

Keywords

  • NFC payment implants
  • Contactless payment hardware
  • Subdermal payment chips
  • Biopolymer implant devices
  • Contactless payment technology

Where Walletmor is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Walletmor business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Marketing or Sales, Operations, Personnel, Infrastructure

Revenue model

  1. Implant Hardware Sales: One-time sale of the Walletmor payment implant device. The implant is sold directly to consumers through the Shopify e-commerce platform. No subscription fees or maintenance charges apply. Revenue is generated entirely from the initial product purchase.
  2. Shipping Fees: Revenue generated from shipping charges for express delivery options. Standard shipping is free; express shipping via DHL Express costs €20.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goWalletmor Payment Implant (8-year validity) - Current generation
One time/ perpetual licensePay-as-you-goLegacy Implant (2-year validity) - Discontinued generation
Unit PricingPay-as-you-goStandard Shipping
Unit PricingPay-as-you-goExpress Shipping (DHL Express)
One time/ perpetual licensePay-as-you-goUS Version Implant

Go-to-market motion2 records

Distribution channels2 records

Marketing channels8 records

Walletmor product offering

Product offering

Core offering

Walletmor designs, manufactures, and sells a subdermal NFC payment implant — a passive transponder consisting of a silicon chip and antenna encapsulated in FDA-confirmed, USP Class VI certified biopolymer. Once implanted (typically in the hand), the device enables contactless payments at any Visa/Mastercard contactless terminal worldwide by linking to an iCard (EU) or Purewrist (US) digital wallet account. The product is sold directly to consumers via e-commerce, with installation arranged separately through partner specialists.

Product overview

Walletmor offers a single core product - the Walletmor Payment Implant - which is a subdermal NFC-based payment device. The implant consists of an NFC chip (storing encrypted payment data), an NFC antenna (for terminal communication), and biopolymer encapsulation. For European customers, the implant links with iCard digital wallet; for US customers, it links with Purewrist. The company plans future expansion through Walletmed - a glucose monitoring implant for diabetics. Walletmor Ltd, registered in London, developed the world's first globally accepted payment implant launched in April 2021.

Differentiator

Problem solved

Functional benefit

Brands

  • Walletmed: A pivot of Walletmor targeting the diabetics market using smart implant technology for glucose monitoring. Plans to create an implant that is irreplaceable, convenient, connected to smartphone, and potentially 10x cheaper than standard glucometers within 10 years.

Products and services

  • Walletmor Payment Implant (EU Version) Subdermal NFC payment implant — a passive transponder with silicon chip and antenna in biocompatible biopolymer casing, designed for permanent implantation (typically in the hand). Enables contactless payments at any Visa/Mastercard contactless POS terminal worldwide by linking to an iCard EU digital wallet account. 8-year validity, sold at €299 (regular €499) with no subscription or per-transaction fees.
  • Walletmor Payment Implant (US Version) US-specific version of the Walletmor subdermal NFC payment implant with identical technical specifications as the EU version, but links to Purewrist digital wallet app for US residents instead of iCard. Priced at €299.

Quantifiable outcome

  • 72.1% of surveyed Poles worry about wallet/card theft, driving demand for theft-proof payment solutions like implants
  • +4 more outcomes

Companies that use Walletmor

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Walletmor technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature4 records

Walletmor partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core.

  • VivoKey Technologies Inc.coreTechnology or Integration · 1 January 2021Seattle-based VivoKey Technologies developed the biocompatible biopolymer used in Walletmor implants. Amal Graafstra, VivoKey founder, serves as Walletmor's CTO. VivoKey is the world's largest producer of its kind implementing the digital identity ecosystem. Their laboratory created the safe biopolymer with USP Class VI certification.
  • iCardcoreTechnology or IntegrationiCard is an independent Financial Institution registered in the European Union holding EMI (Electronic Money Institution) status. Walletmor implants are linked to iCard personal accounts for fund storage. iCard follows strict EU regulations for risk management and security. Customers set up iCard accounts to store disposable funds that are accessed via the implant for contactless payments.
  • PurewristcoreTechnology or IntegrationPurewrist is an independent digital wallet provider for US customers. US version of Walletmor implant links to Purewrist app instead of iCard. Users register at Purewrist, verify identity, and top up accounts for implant-based payments.
  • KSEC Cyborg Center (UK)coreChannel Partner/ Reseller/ DistributorUK-based installation partner with multiple locations including Ipswich, Brackley, and Norwich. Professional body modification specialists offering Walletmor implant installation services.
  • Dr. Szymon Manasterski / Centrum Medyczne MichalakcoreChannel Partner/ Reseller/ DistributorOrthopedic specialist at Michalak Medical Center in Wrocław, Poland. Recommended Walletmor installation partner specializing in musculoskeletal orthopedics and traumatology. Performs quick 4-minute implantation procedures under local anesthesia.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Walletmor competitors and assessment

Company assessment

Market position

Weaknesses1 record

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Walletmor social profiles

Digital presence

Walletmor compliance and trust

Trust signal

Compliance4 records

Walletmor financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Walletmor leadership team

Management profile

Number of profiles

Profiles3 records

Walletmor funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Walletmor M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Walletmor

What does Walletmor do?

Walletmor designs, manufactures, and sells a subdermal NFC payment implant — a passive transponder consisting of a silicon chip and antenna encapsulated in FDA-confirmed, USP Class VI certified biopolymer. Once implanted (typically in the hand), the device enables contactless payments at any Visa/Mastercard contactless terminal worldwide by linking to an iCard (EU) or Purewrist (US) digital wallet account. The product is sold directly to consumers via e-commerce, with installation arranged separately through partner specialists.

Is Walletmor a public or private company?

Walletmor is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Walletmor founded?

Walletmor was founded in 2021. It employs 1 to 10 people.

Where is Walletmor based?

Walletmor is headquartered in London, United Kingdom, in the Europe region.

How does Walletmor make money?

Two revenue lines are on record. Implant Hardware Sales are the primary driver. The others are shipping Fees.

Does Walletmor have an API?

No public API is recorded for Walletmor.

What industry is Walletmor in?

Walletmor's product category is Contactless Payment Hardware. Its primary akta.pro industry code is FSAMAEAB, Mobile Wallets (NFC Tap-to-Pay / HCE), with a secondary code of FSAMAEAM, Embedded Wallets (Platforms & Marketplaces).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PYMNTS.comThe Cyborg Shopper: Is It the Future or Just a Blip?A TikTok video shows a user completing a payment at a fried chicken restaurant using a microchip implanted in his hand, with provider Walletmor promoting such implants. A PYMNTS survey of 2,100 U.S. consumers found 48% used digital wallets for eCommerce and 39% in-store, while 40% rank security as a top concern.FinSMEsPaying With Your Hand Using A MicrochipPatrick Paumen pays with a contactless microchip implanted under his skin, a procedure he claims is painless. Walletmor, a British-Polish firm, is the first to sell such chips, having sold 500. A 2021 survey found 51% of UK and EU respondents would consider using them.BBCThe microchip implants that let you pay with your handWalletmor, a British-Polish firm, became the first to sell implantable contactless payment chips, which weigh less than a gram and use NFC or RFID technology. The company has sold over 500 chips, and a 2021 survey found 51% of people would consider such implants, though privacy and security concerns remain.The Fintech TimesWalletmor Introduces a Payment Implant Chip To Allow For Cardless PaymentsWalletmor, a British-Polish paytech startup, announced its payment implant will roll out across Europe, with nearly 400 users already. The biologically safe implant costs 199 euros and is valid for eight years. It uses NFC technology and is certified to ISO bio-compatibility standards.NFCWBio-compatible NFC implant lets consumers make contactless payments with their handWalletmor, a British-Polish start-up, has launched an NFC payment implant compliant with ISO 10993 biocompatibility standards, making it available to consumers in the European Union and the UK. The batteryless device, about the size of a safety pin and half a millimetre thick, is embedded under the skin and linked to a preloaded account on the European iCard platform, enabling contactless payments wherever standard credit or debit cards are accepted. The implantation procedure is described as painless and takes approximately 15 minutes, with the device activated only when in proximity to a payment terminal.Notes From PolandWorld’s first payment chip that can be implanted under skin launched by Polish-British startupPolish-British startup Walletmor launched the world's first implantable payment chip, half a millimetre long and under a gram, costing €199. It uses NFC for contactless payments and has nearly 200 users, with 34 in Poland. The company aims to add identification and keycard functions.